REG - CVS Group plc - Transaction in Own Shares
13/11/2025 07:00
For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20251113:nRSM3216Ha&default-theme=true
RNS Number : 3216H CVS Group plc 13 November 2025
13 November 2025
CVS GROUP plc
("CVS" or the "Company" and, together with its subsidiaries, the "Group")
Transaction in own shares
CVS announces that on 12 November 2025 it purchased the following number of
its ordinary shares of 0.2 pence each ("Ordinary Shares") from Joh. Berenberg,
Gossler & Co. KG, London Branch ("Berenberg"), in accordance with the
terms of the share buyback programme announced on 24 October 2025 (the "Share
Buyback Programme").
Date of purchase: 12/11/2025
Aggregate number of Ordinary Shares purchased: 25,231
Lowest price paid per share (GBp): 1,182.00
Highest price paid per share (GBp): 1,202.00
Volume weighted average price paid per share (GBp): 1,188.97
CVS intends to cancel all of the purchased Ordinary Shares.
Following settlement of the above purchases and cancellation of the Ordinary
Shares purchased, CVS will have 71,368,658 Ordinary Shares in issue and holds
no Ordinary Shares in treasury.
The total number of voting rights in CVS is therefore 71,368,658 and this
figure may be used by shareholders as the denominator for the calculations by
which they will determine if they are required to notify their interest in, or
a change to their interest in, CVS under the Financial Conduct Authority's
Disclosure and Transparency Rules.
Since the commencement of the Share Buyback Programme, the Company has
repurchased 372,125 Ordinary Shares in aggregate at a weighted average price
of 1,258.21 pence per share.
In accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 (the Market
Abuse Regulation), as it forms part of Retained EU Law as defined in the
European Union (Withdrawal) Act 2018, the table below contains detailed
information of the individual trades made by Berenberg as part of the Share
Buyback Programme.
Individual transactions:
Number of Transaction price (GBp share) Time of Transaction Trading Venue
Ordinary Shares purchased transaction (UK Time) reference number
159 1198 12/11/2025 08:02:45 1331672406559919 XLON
292 1202 12/11/2025 08:09:14 1331672406561276 XLON
71 1200 12/11/2025 08:09:31 1331672406561344 XLON
1 1200 12/11/2025 08:09:31 1331672406561345 XLON
65 1194 12/11/2025 08:49:16 1331672406566636 XLON
74 1194 12/11/2025 08:55:50 1331672406567324 XLON
91 1192 12/11/2025 09:18:55 1331672406570275 XLON
172 1190 12/11/2025 09:30:00 1331672406571736 XLON
172 1186 12/11/2025 09:30:09 1331672406571785 XLON
808 1190 12/11/2025 10:08:18 1331672406575768 XLON
103 1190 12/11/2025 10:08:18 1331672406575773 XLON
72 1192 12/11/2025 10:26:22 1331672406577215 XLON
72 1192 12/11/2025 11:00:43 1331672406580401 XLON
72 1192 12/11/2025 11:02:04 1331672406580539 XLON
170 1192 12/11/2025 11:06:07 1331672406581021 XLON
325 1190 12/11/2025 11:20:56 1331672406582103 XLON
401 1190 12/11/2025 11:52:22 1331672406584766 XLON
196 1192 12/11/2025 12:15:10 1331672406587281 XLON
48 1192 12/11/2025 12:15:10 1331672406587282 XLON
131 1192 12/11/2025 12:52:24 1331672406590763 XLON
56 1192 12/11/2025 12:52:24 1331672406590764 XLON
363 1192 12/11/2025 12:52:24 1331672406590768 XLON
131 1192 12/11/2025 12:52:24 1331672406590770 XLON
187 1192 12/11/2025 12:52:24 1331672406590771 XLON
1177 1192 12/11/2025 12:52:24 1331672406590772 XLON
187 1192 12/11/2025 12:52:24 1331672406590773 XLON
1177 1192 12/11/2025 12:52:24 1331672406590774 XLON
187 1192 12/11/2025 12:52:24 1331672406590775 XLON
1177 1192 12/11/2025 12:52:24 1331672406590776 XLON
187 1192 12/11/2025 12:52:24 1331672406590777 XLON
187 1192 12/11/2025 12:52:24 1331672406590778 XLON
131 1192 12/11/2025 12:52:24 1331672406590779 XLON
59 1192 12/11/2025 12:52:24 1331672406590780 XLON
40 1192 12/11/2025 12:52:25 1331672406590787 XLON
19 1192 12/11/2025 12:52:25 1331672406590788 XLON
16 1192 12/11/2025 12:52:25 1331672406590789 XLON
53 1192 12/11/2025 12:52:27 1331672406590793 XLON
778 1192 12/11/2025 12:52:27 1331672406590795 XLON
187 1192 12/11/2025 12:52:27 1331672406590796 XLON
5 1192 12/11/2025 12:52:27 1331672406590797 XLON
28 1192 12/11/2025 12:52:28 1331672406590798 XLON
23 1192 12/11/2025 12:52:31 1331672406590808 XLON
16 1192 12/11/2025 12:52:34 1331672406590810 XLON
17 1192 12/11/2025 12:52:43 1331672406590821 XLON
103 1192 12/11/2025 12:54:21 1331672406590886 XLON
187 1192 12/11/2025 12:59:46 1331672406591413 XLON
114 1192 12/11/2025 12:59:46 1331672406591414 XLON
55 1192 12/11/2025 12:59:46 1331672406591415 XLON
102 1192 12/11/2025 12:59:46 1331672406591419 XLON
85 1192 12/11/2025 13:09:22 1331672406592124 XLON
175 1194 12/11/2025 13:20:19 1331672406592886 XLON
31 1194 12/11/2025 13:20:19 1331672406592887 XLON
99 1194 12/11/2025 13:20:19 1331672406592889 XLON
187 1192 12/11/2025 13:20:19 1331672406592890 XLON
16 1192 12/11/2025 13:20:25 1331672406592895 XLON
171 1192 12/11/2025 13:20:25 1331672406592896 XLON
187 1192 12/11/2025 13:20:25 1331672406592897 XLON
187 1192 12/11/2025 13:20:25 1331672406592898 XLON
187 1192 12/11/2025 13:20:25 1331672406592899 XLON
187 1192 12/11/2025 13:20:25 1331672406592900 XLON
187 1192 12/11/2025 13:20:25 1331672406592901 XLON
187 1192 12/11/2025 13:20:25 1331672406592902 XLON
187 1192 12/11/2025 13:20:25 1331672406592903 XLON
187 1192 12/11/2025 13:20:25 1331672406592904 XLON
187 1192 12/11/2025 13:20:25 1331672406592905 XLON
187 1192 12/11/2025 13:20:25 1331672406592906 XLON
187 1192 12/11/2025 13:20:25 1331672406592907 XLON
133 1192 12/11/2025 13:20:25 1331672406592908 XLON
21 1192 12/11/2025 13:20:28 1331672406592909 XLON
18 1192 12/11/2025 13:20:34 1331672406592917 XLON
15 1192 12/11/2025 13:20:52 1331672406592934 XLON
186 1192 12/11/2025 13:23:34 1331672406593097 XLON
1 1192 12/11/2025 13:23:34 1331672406593098 XLON
186 1192 12/11/2025 13:23:34 1331672406593099 XLON
82 1192 12/11/2025 13:23:35 1331672406593101 XLON
105 1192 12/11/2025 13:25:15 1331672406593214 XLON
189 1192 12/11/2025 13:25:15 1331672406593216 XLON
73 1190 12/11/2025 13:25:15 1331672406593225 XLON
261 1186 12/11/2025 13:49:37 1331672406595043 XLON
73 1188 12/11/2025 13:53:22 1331672406595350 XLON
823 1186 12/11/2025 14:00:14 1331672406595954 XLON
152 1186 12/11/2025 14:00:14 1331672406595956 XLON
409 1184 12/11/2025 14:05:00 1331672406596504 XLON
16 1184 12/11/2025 14:05:04 1331672406596517 XLON
122 1182 12/11/2025 14:10:34 1331672406597108 XLON
318 1182 12/11/2025 14:10:34 1331672406597114 XLON
337 1182 12/11/2025 14:10:34 1331672406597115 XLON
547 1182 12/11/2025 14:10:34 1331672406597116 XLON
22 1182 12/11/2025 14:16:58 1331672406597794 XLON
716 1182 12/11/2025 14:28:42 1331672406599223 XLON
165 1182 12/11/2025 14:28:42 1331672406599222 XLON
45 1182 12/11/2025 14:28:42 1331672406599225 XLON
187 1182 12/11/2025 14:28:42 1331672406599224 XLON
187 1182 12/11/2025 14:28:42 1331672406599226 XLON
187 1182 12/11/2025 14:28:42 1331672406599227 XLON
187 1182 12/11/2025 14:28:42 1331672406599228 XLON
187 1182 12/11/2025 14:28:42 1331672406599229 XLON
187 1182 12/11/2025 14:28:42 1331672406599230 XLON
187 1182 12/11/2025 14:28:42 1331672406599231 XLON
187 1182 12/11/2025 14:28:42 1331672406599232 XLON
187 1182 12/11/2025 14:28:42 1331672406599233 XLON
187 1182 12/11/2025 14:28:42 1331672406599234 XLON
187 1182 12/11/2025 14:28:42 1331672406599235 XLON
50 1182 12/11/2025 14:28:42 1331672406599236 XLON
137 1182 12/11/2025 14:28:42 1331672406599237 XLON
21 1182 12/11/2025 14:28:43 1331672406599251 XLON
166 1182 12/11/2025 14:28:45 1331672406599295 XLON
394 1182 12/11/2025 14:28:45 1331672406599296 XLON
21 1182 12/11/2025 14:28:46 1331672406599308 XLON
21 1182 12/11/2025 14:28:52 1331672406599332 XLON
145 1182 12/11/2025 14:28:52 1331672406599333 XLON
187 1182 12/11/2025 14:29:01 1331672406599351 XLON
187 1182 12/11/2025 14:29:01 1331672406599352 XLON
18 1182 12/11/2025 14:29:04 1331672406599360 XLON
12 1182 12/11/2025 14:29:59 1331672406599543 XLON
54 1182 12/11/2025 14:30:32 1331672406600205 XLON
16 1182 12/11/2025 14:31:04 1331672406600445 XLON
75 1182 12/11/2025 14:31:07 1331672406600473 XLON
350 1188 12/11/2025 14:43:51 1331672406603720 XLON
10 1188 12/11/2025 14:43:51 1331672406603721 XLON
70 1194 12/11/2025 14:54:17 1331672406605869 XLON
4 1194 12/11/2025 14:54:17 1331672406605870 XLON
358 1194 12/11/2025 15:00:39 1331672406607419 XLON
265 1194 12/11/2025 15:00:39 1331672406607423 XLON
88 1190 12/11/2025 15:01:40 1331672406607657 XLON
339 1188 12/11/2025 15:08:56 1331672406608901 XLON
656 1188 12/11/2025 15:30:41 1331672406612690 XLON
18 1186 12/11/2025 15:30:44 1331672406612700 XLON
194 1186 12/11/2025 15:30:44 1331672406612701 XLON
680 1190 12/11/2025 15:50:49 1331672406615585 XLON
335 1190 12/11/2025 15:52:51 1331672406615957 XLON
23 1190 12/11/2025 15:52:51 1331672406615958 XLON
Contacts
CVS Group
plc
via Camarco
Richard Fairman, CEO
Robin Alfonso, CFO
Paul Higgs, Chief Veterinary Officer
Charlotte Page, Head of Investor Relations
Peel Hunt LLP (Nominated Adviser & Joint
Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Michael Burke / Milo Bonser / Brooke Harris-Lowing
Camarco (Financial
PR)
cvsg@camarco.co.uk
Ginny
Pulbrook
+44 (0)7961 315 138
Letaba Rimell
Tilly Butcher
About CVS Group plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of veterinary services with operations in
the UK and Australia. CVS is focused on providing high-quality clinical
services to its clients and their animals, with outstanding and dedicated
clinical teams and support colleagues at the core of its strategy.
The Group now operates c.470 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours sites.
Alongside the core Veterinary Practices division, CVS operates Laboratories
(providing diagnostic services to CVS and third-parties) and an online retail
business ("Animed Direct").
The Group employs c.8,900 personnel, including c.2,400 veterinary surgeons and
c.3,300 nurses.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END POSGPGAWGUPAGRP
Copyright 2019 Regulatory News Service, all rights reservedRecent news on CVS
See all newsREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Standard form for notification of major holdings
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - Transaction in Own Shares
AnnouncementREG - CVS Group plc - PDMR Dealing
Announcement